Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.
about
Safety profiles of old and new antimicrobials for the treatment of MRSA infections.Role of telavancin in treatment of skin and skin structure infectionsNovel classes of antibiotics or more of the same?Acquired vancomycin resistance in clinically relevant pathogens.Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unitResistant pathogen-associated skin and skin-structure infections: antibiotic options.Treatment of prosthetic osteoarticular infections.Update on carbohydrate-containing antibacterial agents.New antibiotics for bad bugs: where are we?Development of novel antibacterial drugs to combat multiple resistant organisms.Glycopeptide antibiotics: evolving resistance, pharmacology and adverse event profile.Bromomethylthioindole Inspired Carbazole Hybrids as Promising Class of Anti-MRSA Agents.Tissue pharmacokinetics of telavancin in healthy volunteers: a microdialysis study.Novel systemic antibiotics in dermatology.
P2860
Q33429168-9794F130-7CE5-4BF4-888B-B1EF1E5F5D6BQ34620329-A033A211-9480-47B9-8460-F2BFC32BA8F0Q34903245-D76F42A1-8CAD-40FB-A143-9B4ECD667717Q37277083-DB0C9EBF-4E32-49D3-BDAA-440F77124690Q37443022-213224C3-F91E-4D54-B846-887CB2EB9C8DQ37785546-57B787BD-8D83-47E2-954F-7F845DB583F1Q37853179-BB667505-6682-4CAC-BF29-04FF93FAF9A2Q38089193-82327D33-6F90-4193-9E8F-42DF8C2E3C3CQ38132217-3BF5EB5B-A5FF-4703-A2BB-CB476BF75E1BQ38350301-FB5D0D2E-AF34-4FD2-AF13-96FC6703DD2FQ38545589-A07A945D-F15D-4764-A72D-3C8E7C05AB36Q39085473-8CB005DF-6AB6-4FE1-9899-B2208A459523Q39520227-1297935A-3457-4847-9ED2-BED03C4AE2A4Q39616901-A735C77C-B586-4F5E-AE36-3CA94A51B842
P2860
Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dalbavancin and telavancin: no ...... t of Gram-positive infections.
@en
Dalbavancin and telavancin: no ...... t of Gram-positive infections.
@nl
type
label
Dalbavancin and telavancin: no ...... t of Gram-positive infections.
@en
Dalbavancin and telavancin: no ...... t of Gram-positive infections.
@nl
prefLabel
Dalbavancin and telavancin: no ...... t of Gram-positive infections.
@en
Dalbavancin and telavancin: no ...... t of Gram-positive infections.
@nl
P2093
P2860
P356
P1476
Dalbavancin and telavancin: no ...... nt of Gram-positive infections
@en
P2093
Alfred S Gin
Daryl J Hoban
Ethan Rubinstein
James A Karlowsky
Mel DeCorby
Shannon Trapp
P2860
P356
10.1586/14787210.6.1.67
P577
2008-02-01T00:00:00Z